Get 40% Off
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list

UPDATE 2-Nigeria expects first 4 million coronavirus vaccine doses from COVAX next week -WHO

Published 26/02/2021, 18:37
Updated 26/02/2021, 20:18
© Reuters

* Africa's most populous country has had fewer than 1,900
deaths
* Nigeria will not seek bilateral deals, says disease centre
chief

(Adds officials' quotes, vaccine details)
By Michael Shields and Stephanie Nebehay
GENEVA, Feb 26 (Reuters) - Nigeria is expecting its first 4
million doses of coronavirus vaccines next week from the global
COVAX programme for poor and middle-income countries, the World
Health Organization said on Friday.
Walter Kazadi Mulombo, head of WHO's mission in Nigeria,
told a briefing by video link that Nigeria was expecting 14
million doses in total.
Chikwe Ihekweazu, Director General of the Nigeria Centre for
Disease Control (NCDC), said the situation in Nigeria was so far
much better than had been widely predicted early in the
pandemic.
Nigeria, Africa's most populous country with some 200
million people, has reported fewer than 1,900 COVID-19 deaths so
far.
"The whole world expected the continent of Africa, and
Nigeria with our social and economic realities, to basically
fall apart," Ihekweazu told the briefing.
He also referred to the findings of seroprevalence studies,
published on Monday, which suggested that 23% of Lagos state
inhabitants - around 4 million people - may have had COVID-19 in
October.
He said studies in four Nigerian states had shown that
serious illness appeared to be rarer than feared, possibly in
part because of the young average age of the population.
"Getting the vaccine into Nigeria will serve the continent
well, will serve the world well," he said.
Nigeria plans to inoculate 40% of the population this year
and 30% more in 2022.
Ihekweazu said authorities recognised the need for equity in
access to vaccines and was committed to pursuing multilateral
deals.
"We will not look for bilateral deals," Ihekweazu said.
"We will work in a multilateral way with WHO, with COVAX
with the African Union (AU) to make sure that as we get vaccines
into Nigeria, the same happens ... across the continent," he
said.

<^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^
GRAPHIC-COVID-19 Global Tracker https://graphics.reuters.com/world-coronavirus-tracker-and-maps/
^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^>

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.